FdaApplication
ANDA 090384
Identifiers
- fda_app_no: ANDA090384
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2022-05-25 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 750MG BASE/VIAL | POWDER;INTRAVENOUS |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 1GM BASE/VIAL | POWDER;INTRAVENOUS |
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS |
4 products